Quantum量子訊息有限公司

Heart Failure POC and LOC Devices Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-09-03　·　256 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 185.7 Mn
2033 年預估規模
USD 498.4 Mn
年複合成長率 CAGR
15.1%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

申請 Sample
完整報告名稱與涵蓋範圍
Heart Failure POC and LOC Devices Market, By Device Type (Point-of-Care (POC) Devices, Lab-on-Chip (LOC) Devices), By Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Biomarker (BNP/NT-proBNP, Troponin, Multi-Biomarker Panels, Others), By Technology (Microfluidics, Array-Based Systems, Immunoassay-Based Systems, Other), By Application (Acute Heart Failure Diagnosis, Chronic Heart Failure Monitoring, Risk Stratification and Readmission Prevention, Therapy Optimization, Others), By End User (Hospitals, Specialty Cardiology Centers, Primary Care and Urgent Care Centers, Diagnostic Laboratories, Homecare and Remote Patient Monitoring, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

The global heart failure POC and LOC devices market is estimated to be valued at USD 185.7 Mn in 2026 and is expected to reach USD 498.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 15.1% from 2026 to 2033. Heart failure is a chronic, progressive disease of the cardiovascular system affecting more than 64 million people worldwide, where the heart fails to pump sufficient blood to meet the body’s oxygen and metabolic needs. The increasing disease burden is driving the need for rapid and accurate diagnostic solutions for biomarkers such as BNP, NT-proBNP, troponin. Point-of-Care (POC) and Lab-on-Chip (LOC) devices are enabling rapid and decentralized cardiac testing in emergency departments, clinics, and home-care settings. Progress in microfluidics, biosensors, nanotechnology, and digital health is making these technologies more portable, accurate, and efficient, thus facilitating their expanding contribution to modern heart-failure diagnosis and monitoring. Market Dynamics The global heart failure POC and LOC devices market is driven by increase in the prevalence of heart failure as well as increase in the aging population along with increase in the prevalence of hypertension, diabetes, obesity and coronary artery disease. The increase in the preference for decentralized patient-centric care and advances in microfluidics, biosensors, wireless connectivity and artificial intelligence is further increasing the demand for rapid and accurate cardiac diagnostics in emergency, outpatient and remote-care settings. However, a number of constraints are present in the market, such as high development and manufacturing costs, strict regulatory requirements, accuracy concerns, limited healthcare infrastructure, and reimbursement challenges. Nevertheless, growing demand for home-based cardiac monitoring, IoT-connected diagnostics, cloud-based data management, and predictive analytics, coupled with improving healthcare access in emerging economies will offer new opportunities for growth in the global heart failure POC and LOC devices market. Key Features of the Study • This report provides in-depth analysis of the global heart failure POC and LOC devices market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global heart failure POC and LOC devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Danaher Corporation, QuidelOrtho Corporation, bioMérieux S.A., Becton, Dickinson and Company, Trinity Biotech plc, Jant Pharmacal Corporation, and Werfen, S.A. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global heart failure POC and LOC devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heart failure POC and LOC devices market Market Segmentation • Device Type Insights (Revenue, USD Mn, 2021 - 2033) o Point-of-Care (POC) Devices o Lab-on-Chip (LOC) Devices • Test Type Insights (Revenue, USD Mn, 2021 - 2033) o Proteomic Testing o Metabolomic Testing o Genomic Testing • Biomarker Insights (Revenue, USD Mn, 2021 - 2033) o BNP/NT-proBNP o Troponin o Multi-Biomarker Panels o Others • Technology Insights (Revenue, USD Mn, 2021 - 2033) o Microfluidics o Array-Based Systems o Immunoassay-Based Systems o Others • Application Insights (Revenue, USD Mn, 2021 - 2033) o Acute Heart Failure Diagnosis o Chronic Heart Failure Monitoring o Risk Stratification and Readmission Prevention o Therapy Optimization o Others • End User Insights (Revenue, USD Mn, 2021 - 2033) o Hospitals o Specialty Cardiology Centers o Primary Care and Urgent Care Centers o Diagnostic Laboratories o Homecare and Remote Patient Monitoring o Others • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Abbott Laboratories o Hoffmann-La Roche Ltd o Siemens Healthineers AG o Danaher Corporation o QuidelOrtho Corporation o bioMérieux S.A. o Becton, Dickinson and Company o Trinity Biotech plc o Jant Pharmacal Corporation o Werfen, S.A.

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Heart Failure POC and LOC Devices Market, By Device Type  Global Heart Failure POC and LOC Devices Market, By Test Type  Global Heart Failure POC and LOC Devices Market, By Biomarker  Global Heart Failure POC and LOC Devices Market, By Technology  Global Heart Failure POC and LOC Devices Market, By Application  Global Heart Failure POC and LOC Devices Market, By End User  Global Heart Failure POC and LOC Devices Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Device Type Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Heart Failure POC and LOC Devices Market, By Device Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Point-of-Care (POC) Devices  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Lab-on-Chip (LOC) Devices  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Heart Failure POC and LOC Devices Market, By Test Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Proteomic Testing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Metabolomic Testing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Genomic Testing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Heart Failure POC and LOC Devices Market, By Biomarker, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o BNP/NT-proBNP  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Troponin  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Multi-Biomarker Panels  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Heart Failure POC and LOC Devices Market, By Technology, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Microfluidics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Array-Based Systems  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Immunoassay-Based Systems  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Heart Failure POC and LOC Devices Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Acute Heart Failure Diagnosis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Chronic Heart Failure Monitoring  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Risk Stratification and Readmission Prevention  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Therapy Optimization  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global Heart Failure POC and LOC Devices Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Specialty Cardiology Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Primary Care and Urgent Care Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Diagnostic Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Homecare and Remote Patient Monitoring  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 10. Global Heart Failure POC and LOC Devices Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 11. Competitive Landscape o Abbott Laboratories  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o Hoffmann-La Roche Ltd.  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o Siemens Healthineers AG  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o Danaher Corporation  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o QuidelOrtho Corporation  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o bioMerieux S.A.  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o Becton, Dickinson and Company  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o Trinity Biotech plc  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o Jant Pharmacal Corporation  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies o Werfen, S.A.  Company Highlights  Device Type Portfolio  Key Developments  Financial Performance  Strategies 12. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 13. References and Research Methodology o References o Research Methodology o About us Browse 32 market data tables and 28 figures on ‘Heart Failure POC and LOC Devices Market' - Global forecast to 2033

提及公司

Abbott LaboratoriesHoffmann-La Roche LtdSiemens Healthineers AGDanaher CorporationQuidelOrtho CorporationbioMérieux S.A.Becton, Dickinson and CompanyTrinity Biotech plcJant Pharmacal CorporationWerfen, S.A.

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們